Acumen Pharmaceuticals, INC Form 4 insider transactions

NASDAQ
Director Derrell Porter acquired 25,000 stock options in Acumen Pharmaceuticals on June 10, 2024.
NASDAQ
Director Nathan B. Fountain acquired 25,000 stock options in Acumen Pharmaceuticals, Inc. on June 10, 2024.
NASDAQ
Director Kimberlee C Drapkin acquired 25,000 stock options in Acumen Pharmaceuticals on June 10, 2024.